Neural tube defects: Recent advances, unsolved questions, and controversies

The Lancet Neurology

Volumn 12, Issue 8, 2013, Pages 799-810

  Copp, Andrew J ^a   Stanier, Philip ^a   Greene, Nicholas DE ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FETOPROTEIN; FOLIC ACID; RETINOL;

ACETYLATION; AMNION FLUID; ANENCEPHALUS; BRAIN DISEASE; CELL DIVISION; CELL PROLIFERATION; CLINICAL FEATURE; CRANIORACHISCHISIS; DEACETYLATION; DISEASE SEVERITY; DNA REPLICATION; ECHOGRAPHY; EDUCATION; ENCEPHALOCELE; ENVIRONMENTAL FACTOR; FETUS SURGERY; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; FOLATE METABOLISM; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEREDITY; HETEROZYGOSITY; HIGH TEMPERATURE; HUMAN; HYDROCEPHALUS; INCIDENCE; LIPOMA; MATERNAL BLOOD; MATERNAL DIABETES MELLITUS; MATERNAL OBESITY; MENINGOMYELOCELE; NERVE CELL DIFFERENTIATION; NEURAL TUBE DEFECT; NEURULATION; NONHUMAN; PATHOGENESIS; PRENATAL DIAGNOSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; RISK FACTOR; SEX RATIO; SPINAL DYSRAPHISM; STILLBIRTH; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANIMALS; DATABASES, FACTUAL; DISEASE MODELS, ANIMAL; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; NEURAL TUBE DEFECTS;

EID: 84880329695     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70110-8     Document Type: Review

References (126)

1. Mitchell LE Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet 2005, 135:88-94.
2. Creasy MR, Alberman ED Congenital malformations of the central nervous system in spontaneous abortions. J Med Genet 1976, 13:9-16.
3. Dolk H, Loane M, Garne E The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 2010, 686:349-364.
4. Obladen M Cats, frogs, and snakes: early concepts of neural tube defects. J Child Neurol 2011, 26:1452-1461.
5. Record RG, McKeown T Congenital malformations of the central nervous system. I-A survey of 930 cases. Br J Soc Med 1949, 4:183-219.
6. Carter CO Clues to the aetiology of neural tube malformations. Dev Med Child Neurol 1974, 16(suppl 32):3-15.
7. Moore CA, Li S, Li Z, et al. Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am J Med Genet 1997, 73:113-118.
8. McNeely PD, Howes WJ Ineffectiveness of dietary folic acid supplementation on the incidence of lipomyelomeningocele: pathogenetic implications. J Neurosurg 2004, 100:98-100.
9. Dolk H, De Wals P, Gillerot Y, et al. Heterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalence. Teratology 1991, 44:547-559.
10. Johnson KM, Suarez L, Felkner MM, Hendricks K Prevalence of craniorachischisis in a Texas-Mexico border population. Birth Defects Res Part A Clin Mol Teratol 2004, 70:92-94.
11. Lorber J Results of treatment of myelomeningocele. An analysis of 524 unselected cases with special reference to possible selection for treatment. Dev Med Child Neurol 1971, 13:279-303.
12. Brock DJH, Sutcliffe RG Early prenatal diagnosis of anencephaly. Lancet 1972, 300:1252-1253.
13. Seller MJ, Coltart TM, Campbell S, Singer JD Early termination of anencephalic pregnancy after detection by raised alpha-fetoprotein levels. Lancet 1973, 302:73.
14. Cameron M, Moran P Prenatal screening and diagnosis of neural tube defects. Prenatal Diag 2009, 29:402-411.
15. Stiefel D, Shibata T, Meuli M, Duffy PG, Copp AJ Tethering of the spinal cord in mouse fetuses and neonates with spina bifida. J Neurosurg (Spine) 2003, 99:206-213.
16. Wood LR, Smith MT Generation of anencephaly: 1. Aberrant neurulation and 2. Conversion of exencephaly to anencephaly. J Neuropathol Exp Neurol 1984, 43:620-633.
17. Adzick NS, Sutton LN, Crombleholme TM, Flake AW Successful fetal surgery for spina bifida. Lancet 1998, 352:1675-1676.
18. Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011, 364:993-1004.
19. Smithells RW, Sheppard S, Schorah CJ Vitamin deficiencies and neural tube defects. Arch Dis Child 1976, 51:944-950.
20. Smithells RW, Sheppard S, Schorah CJ, et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 1981, 56:911-918.
21. Wald NJ, Polani PE Neural-tube defects and vitamins: the need for a randomized clinical trial. Br J Obstet Gynaecol 1984, 91:516-523.
22. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991, 338:131-137. MRC Vitamin Study Research Group.
23. Czeizel AE, Dudás I Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327:1832-1835.
24. Berry RJ, Li Z, Erickson JD, Li S, et al. Prevention of neural-tube defects with folic acid in China. N Engl J Med 1999, 341:1485-1490.
25. Abramsky L, Botting B, Chapple J, Stone D Has advice on periconceptional folate supplementation reduced neural-tube defects?. Lancet 1999, 354:998-999.
26. Oakley GP, Erickson JD, Adams MJ Urgent need to increase folic acid consumption. JAMA 1995, 274:1717-1718.
27. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001, 285:2981-2986.
28. Eichholzer M, Tonz O, Zimmermann R Folic acid: a public-health challenge. Lancet 2006, 367:1352-1361.
29. Taylor TN, Farkouh RA, Graham JB, et al. Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States. Am J Obstet Gynecol 2011, 205:460-468.
30. Prinz-Langenohl R, Bramswig S, Tobolski O, et al. [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C->T polymorphism of methylenetetrahydrofolate reductase. Br J Pharmacol 2009, 158:2014-2021.
31. Green TJ, Liu Y, Dadgar S, Li W, Böhni R, Kitts DD Wheat rolls fortified with microencapsulated L-5-methyltetrahydrofolic acid or equimolar folic acid increase blood folate concentrations to a similar extent in healthy men and women. J Nutr 2013, published online April 24. 10.3945/jn.113.174268.
32. Wald NJ, Law MR, Morris JK, Wald DS Quantifying the effect of folic acid. Lancet 2001, 358:2069-2073.
33. Heseker HB, Mason JB, Selhub J, Rosenberg IH, Jacques PF Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br J Nutr 2008, 16:1-8.
34. Mosley BS, Cleves MA, Siega-Riz AM, et al. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 2009, 169:9-17.
35. Copp AJ, Greene NDE, Murdoch JN The genetic basis of mammalian neurulation. Nat Rev Genet 2003, 4:784-793.
36. Greene NDE, Copp AJ Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med 1997, 3:60-66.
37. Cockroft DL Changes with gestational age in the nutritional requirements of postimplantation rat embryos in culture. Teratology 1988, 38:281-290.
38. Prevention of neural tube defects by inositol in conjunction with folic acid (PONTI Study) Institute of Child Health, (accessed June 6, 2013). http://www.clinicaltrials.gov/ct2/show/NCT00452829.
39. Vandevijvere S, Amsalkhir S, Van Oyen H, Moreno-Reyes R Determinants of folate status in pregnant women: results from a national cross-sectional survey in Belgium. Eur J Clin Nutr 2012, 66:1172-1177.
40. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993, 86:703-708.
41. Scott JM Folate and vitamin B12. Proc Nutr Soc 1999, 58:441-448.
42. Heid MK, Bills ND, Hinrichs SH, Clifford AJ Folate deficiency alone does not produce neural tube defects in mice. J Nutr 1992, 122:888-894.
43. Burgoon JM, Selhub J, Nadeau M, et al. Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model. Teratology 2002, 65:219-227.
44. Burren KA, Savery D, Massa V, et al. Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function. Hum Mol Genet 2008, 17:3675-3685.
45. Beaudin AE, Abarinov EV, Noden DM, et al. Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. Am J Clin Nutr 2011, 93:789-798.
46. Hook EB, Czeizel AE Can terathanasia explain the protective effect of folic-acid supplementation on birth defects?. Lancet 1997, 350:513-515.
47. Fleming A, Copp AJ Embryonic folate metabolism and mouse neural tube defects. Science 1998, 280:2107-2109.
48. Martinez-Barbera JP, Rodriguez TA, Greene NDE, et al. Folic acid prevents exencephaly in Cited2 deficient mice. Hum Mol Genet 2002, 11:283-293.
49. Marean A, Graf A, Zhang Y, Niswander L Folic acid supplementation can adversely affect murine neural tube closure and embryonic survival. Hum Mol Genet 2011, 20:3678-3683.
50. Harris MJ Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants. Birth Defects Res A Clin Mol Teratol 2008, 85:331-339.
51. Greene NDE, Stanier P, Copp AJ Genetics of human neural tube defects. Hum Mol Genet 2009, 18:R113-R129.
52. Smith JL, Schoenwolf GC Cell cycle and neuroepithelial cell shape during bending of the chick neural plate. Anat Rec 1987, 218:196-206.
53. Copp AJ, Brook FA, Roberts HJ A cell-type-specific abnormality of cell proliferation in mutant (curly tail) mouse embryos developing spinal neural tube defects. Development 1988, 104:285-295.
54. Greene ND, Stanier P, Moore GE The emerging role of epigenetic mechanisms in the aetiology of neural tube defects. Epigenetics 2011, 6:875-883.
55. Leck I Causation of neural tube defects: clues from epidemiology. Br Med Bull 1974, 30:158-163.
56. Rampersaud E, Melvin EC, Speer MC Nonsyndromic neural tube defects: genetic basis and genetic investigations. Neural tube defects: from origin to treatment 2006, 165-175. Oxford University Press, Oxford. D.F. Wyszynski (Ed.).
57. Boyles AL, Hammock P, Speer MC Candidate gene analysis in human neural tube defects. Am J Med Genet C Semin Med Genet 2005, 135:9-23.
58. Etheredge AJ, Finnell RH, Carmichael SL, et al. Maternal and infant gene-folate interactions and the risk of neural tube defects. Am J Med Genet A 2012, 158A:2439-2446.
59. Amorim MR, Lima MA, Castilla EE, Orioli IM Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C > T: a meta-analysis. Am J Med Genet A 2007, 143A:1726-1732.
60. Brody LC, Conley M, Cox C, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 2002, 71:1207-1215.
61. Parle-McDermott A, Pangilinan F, O'Brien KK, et al. A common variant in MTHFD1L is associated with neural tube defects and mRNA splicing efficiency. Hum Mutat 2009, 30:1650-1656.
62. Narisawa A, Komatsuzaki S, Kikuchi A, et al. Mutations in genes encoding the glycine cleavage system predispose to neural tube defects in mice and humans. Hum Mol Genet 2012, 21:1496-1503.
63. Pike ST, Rajendra R, Artzt K, Appling DR Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos. J Biol Chem 2010, 285:4612-4620.
64. Dunlevy LPE, Chitty LS, Doudney K, et al. Abnormal folate metabolism in foetuses affected by neural tube defects. Brain 2007, 130:1043-1049.
65. Momb J, Lewandowski JP, Bryant JD, et al. Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice. Proc Natl Acad Sci USA 2013, 110:549-554.
66. Chen ZT, Karaplis AC, Ackerman SL, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001, 10:433-443.
67. Beaudin AE, Perry CA, Stabler SP, Allen RH, Stover PJ Maternal Mthfd1 disruption impairs fetal growth but does not cause neural tube defects in mice. Am J Clin Nutr 2012, 95:882-891.
68. Wallingford JB, Harland RM Neural tube closure requires Dishevelled-dependent convergent extension of the midline. Development 2002, 129:5815-5825.
69. Ybot-Gonzalez P, Savery D, Gerrelli D, et al. Convergent extension, planar-cell-polarity signalling and initiation of mouse neural tube closure. Development 2007, 134:789-799.
70. Keller R, Shook D, Skoglund P The forces that shape embryos: physical aspects of convergent extension by cell intercalation. Phys Biol 2008, 5:15007.
71. Montcouquiol M, Crenshaw EB, Kelley MW Noncanonical Wnt signaling and neural polarity. Annu Rev Neurosci 2006, 29:363-386.
72. Greene ND, Gerrelli D, Van Straaten HW, Copp AJ Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects. Mech Dev 1998, 73:59-72.
73. Robinson A, Escuin S, Doudney K, et al. Mutations in the planar cell polarity genes CELSR1 and SCRIB are associated with the severe neural tube defect craniorachischisis. Hum Mutat 2012, 33:440-447.
74. Curtin JA, Quint E, Tsipouri V, et al. Mutation of Celsr1 disrupts planar polarity of inner ear hair cells and causes severe neural tube defects in the mouse. Curr Biol 2003, 13:1-20.
75. Etheridge SL, Ray S, Li S, et al. Murine dishevelled 3 functions in redundant pathways with dishevelled 1 and 2 in normal cardiac outflow tract, cochlea, and neural tube development. PLoS Genet 2008, 4:e1000259.
76. De Marco P, Merello E, Consales A, et al. Genetic analysis of Disheveled 2 and Disheveled 3 in human neural tube defects. J Mol Neurosci 2013, 49:582-588.
77. Seo JH, Zilber Y, Babayeva S, et al. Mutations in the planar cell polarity gene, Fuzzy, are associated with neural tube defects in humans. Hum Mol Genet 2011, 20:4324-4333.
78. Wang Y, Guo N, Nathans J The role of Frizzled3 and Frizzled6 in neural tube closure and in the planar polarity of inner-ear sensory hair cells. J Neurosci 2006, 26:2147-2156.
79. De Marco P, Merello E, Rossi A, et al. FZD6 is a novel gene for human neural tube defects. Hum Mutat 2012, 33:384-390.
80. Bosoi CM, Capra V, Allache R, et al. Identification and characterization of novel rare mutations in the planar cell polarity gene PRICKLE1 in human neural tube defects. Hum Mutat 2011, 32:1371-1375.
81. Lu X, Borchers AG, Jolicoeur C, et al. PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 2004, 430:93-98.
82. Murdoch JN, Henderson DJ, Doudney K, et al. Disruption of scribble (Scrb1) causes severe neural tube defects in the circletail mouse. Hum Mol Genet 2003, 12:87-98.
83. Wansleeben C, Feitsma H, Montcouquiol M, Kroon C, Cuppen E, Meijlink F Planar cell polarity defects and defective Vangl2 trafficking in mutants for the COPII gene Sec24b. Development 2010, 137:1067-1073.
84. Kibar Z, Torban E, McDearmid JR, et al. Mutations in VANGL1 associated with neural-tube defects. N Engl J Med 2007, 356:1432-1437.
85. Torban E, Patenaude AM, Leclerc S, et al. Genetic interaction between members of the Vangl family causes neural tube defects in mice. Proc Natl Acad Sci USA 2008, 105:3449-3454.
86. Kibar Z, Bosoi CM, Kooistra M, et al. Novel mutations in VANGL1 in neural tube defects. Hum Mutat 2009, 30:E706-E715.
87. Lei YP, Zhang T, Li H, Wu BL, Jin L, Wang HY VANGL2 mutations in human cranial neural tube defects. N Engl J Med 2010, 362:2232-2235.
88. Kibar Z, Salem S, Bosoi CM, et al. Contribution of VANGL2 mutations to isolated neural tube defects. Clin Genet 2010, 80:76-82.
89. Murdoch JN, Doudney K, Paternotte C, Copp AJ, Stanier P Severe neural tube defects in the loop-tail mouse result from mutation of Lpp1, a novel gene involved in floor plate specification. Hum Mol Genet 2001, 10:2593-2601.
90. Kibar Z, Vogan KJ, Groulx N, Justice MJ, Underhill DA, Gros P Ltap, a mammalian homolog of Drosophila Strabismus/Van Gogh, is altered in the mouse neural tube mutant Loop-tail. Nat Genet 2001, 28:251-255.
91. Reynolds A, McDearmid JR, Lachance S, et al. VANGL1 rare variants associated with neural tube defects affect convergent extension in zebrafish. Mech Dev 2010, 127:385-392.
92. Logan CV, Abdel-Hamed Z, Johnson CA Molecular genetics and pathogenic mechanisms for the severe ciliopathies: insights into neurodevelopment and pathogenesis of neural tube defects. Mol Neurobiol 2010, 43:12-26.
93. Copp AJ, Greene NDE Genetics and development of neural tube defects. J Pathol 2010, 220:217-230.
94. Lammer EJ, Sever LE, Oakley GP Teratogen update: valproic acid. Teratology 1987, 35:465-473.
95. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001, 153:961-968.
96. Menegola E, Di Renzo F, Broccia ML, et al. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. Birth Defects Res B Dev Reprod Toxicol 2005, 74:392-398.
97. Missmer SA, Suarez L, Felkner M, et al. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Health Perspect 2006, 114:237-241.
98. Gelineau-van Waes J, Rainey MA, Maddox JR, et al. Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720. Birth Defects Res A Clin Mol Teratol 2012, 94:790-803.
99. Soler NG, Walsh CH, Malins JM Congenital malformations in infants of diabetic mothers. Q J Med 1976, 45:303-313.
100. Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol 2008, 198:611-619.
101. Moretti ME, Bar-Oz B, Fried S, Koren G Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 2005, 16:216-219.
102. Finnell RH, Bennett GD, Karras SB, Mohl VK Common hierarchies of susceptibility to the induction of neural tube defects in mouse embryos by valproic acid and its 4-propyl-4-pentenoic acid metabolite. Teratology 1988, 38:313-320.
103. Davidson CM, Northrup H, King TM, et al. Genes in glucose metabolism and association with spina bifida. Reprod Sci 2008, 15:51-58.
104. Lupo PJ, Canfield MA, Chapa C, et al. Diabetes and obesity-related genes and the risk of neural tube defects in the national birth defects prevention study. Am J Epidemiol 2012, 176:1101-1109.
105. Doudney K, Ybot-Gonzalez P, Paternotte C, et al. Analysis of the planar cell polarity gene Vangl2 and its co-expressed paralogue Vangl1 in neural tube defect patients. Am J Med Genet A 2005, 136A:90-92.
106. Harris MJ, Juriloff DM An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res A Clin Mol Teratol 2010, 88:653-669.
107. Sadler TW Culture of early somite mouse embryos during organogenesis. J Embryol Exp Morphol 1979, 49:17-25.
108. Massarwa R, Niswander L In toto live imaging of mouse morphogenesis and new insights into neural tube closure. Development 2013, 140:226-236.
109. Garcia-Lopez R, Pombero A, Martinez S Fate map of the chick embryo neural tube. Dev Growth Differ 2009, 51:145-165.
110. Suzuki M, Morita H, Ueno N Molecular mechanisms of cell shape changes that contribute to vertebrate neural tube closure. Dev Growth Differ 2012, 54:266-276.
111. Tawk M, Araya C, Lyons DA, et al. A mirror-symmetric cell division that orchestrates neuroepithelial morphogenesis. Nature 2007, 446:797-800.
112. Van Allen MI, Kalousek DK, Chernoff GF, et al. Evidence for multi-site closure of the neural tube in humans. Am J Med Genet 1993, 47:723-743.
113. O'Rahilly R, Müller F The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratology 2002, 65:162-170.
114. Copp AJ Neurulation in the cranial region-normal and abnormal. J Anat 2005, 207:623-635.
115. Schoenwolf GC Histological and ultrastructural studies of secondary neurulation of mouse embryos. Am J Anat 1984, 169:361-374.
116. Lemire RJ Variations in development of the caudal neural tube in human embryos (Horizons XIV-XXI). Teratology 1969, 2:361-370.
117. Cambray N, Wilson V Axial progenitors with extensive potency are localised to the mouse chordoneural hinge. Development 2002, 129:4855-4866.
118. Copp AJ, Checiu I, Henson JN Developmental basis of severe neural tube defects in the loop-tail (Lp) mutant mouse: use of microsatellite DNA markers to identify embryonic genotype. Dev Biol 1994, 165:20-29.
119. Ybot-Gonzalez P, Gaston-Massuet C, Girdler G, et al. Neural plate morphogenesis during mouse neurulation is regulated by antagonism of BMP signalling. Development 2007, 134:3203-3211.
120. Van Straaten HWM, Copp AJ Curly tail: a 50-year history of the mouse spina bifida model. Anat Embryol 2001, 203:225-237.
121. Sulik KK, Zuker RM, Dehart DB, et al. Normal patterns of neural tube closure differ in the human and the mouse. Proc Greenwood Genetic Center 1998, 18:129-130.
122. Nakatsu T, Uwabe C, Shiota K Neural tube closure in humans initiates at multiple sites: evidence from human embryos and implications for the pathogenesis of neural tube defects. Anat Embryol 2000, 201:455-466.
123. MacDonald KB, Juriloff DM, Harris MJ Developmental study of neural tube closure in a mouse stock with a high incidence of exencephaly. Teratology 1989, 39:195-213.
124. Golden JA, Chernoff GF Intermittent pattern of neural tube closure in two strains of mice. Teratology 1993, 47:73-80.
125. Copp AJ Neural Tube Defects, Molecular Biology of. Encyclopedia of molecular cell biology and molecular medicine 2005, 119-138. John Wiley & Sons, Chichester. R.A. Meyers (Ed.).
126. Copp AJ. Neural Tube Defects. In: eLS, 2008; published online Sept 15. http://dx.doi.org/10.1002/9780470015902.a0000804.pub2.